20 articles
Anat Stemmer‐Rachamimov
Anat Stemmer-Rachamimov, also published as Anat O. Stemmer-Rachamimov, is a neuropathologist and Associate Professor of Pathology at Harvard Medical School and Massachusetts General Hospital, known for research on neurofibromatosis.
Anders A. F. Sima
Anders A. F. Sima is a Swedish-trained neuropathologist known for research on diabetic neuropathy and the polyol pathway, and a professor at Wayne State University.
Andreas von Deimling
Andreas von Deimling is a German neuropathologist who has chaired neuropathology at Heidelberg University since 2007 and developed IDH1-R132H and BRAF-V600E antibodies underpinning WHO glioma classification.
Cynthia Hawkins
Cynthia E. Hawkins is a Canadian pediatric neuropathologist and molecular geneticist at SickKids in Toronto, known for defining the molecular subgroups of pediatric brain tumors.
Declan McGuone
Declan McGuone is an Irish-trained neuropathologist and Associate Professor of Pathology at Yale School of Medicine, known for NEJM case records and a rabies incubation study.
Derek H. Oakley
Derek H. Oakley is an American neuropathologist and stem cell biologist at Harvard Medical School and Massachusetts General Hospital who studies Alzheimer's disease using patient-derived stem cells.
E. Tessa Hedley‐Whyte
E. Tessa Hedley-Whyte, also known as E. T. Hedley-Whyte, is a British-born American neuropathologist and Harvard Medical School professor of pathology at Massachusetts General Hospital.
Harry V. Vinters
Harry V. Vinters is a Canadian-born neuropathologist, Distinguished Professor emeritus at UCLA, who led its neuropathology section from 1993 to 2016 and studied cerebral amyloid angiopathy and epilepsy.
Ingmar Blümcke
Ingmar Blümcke, born 1965, is a German neuropathologist and professor at Erlangen known for leading the ILAE classifications of focal cortical dysplasia and hippocampal sclerosis.
James A. R. Nicoll
James A. R. Nicoll is a British clinical neuropathologist and Professor of Neuropathology at the University of Southampton, known for the first neuropathological study of an Alzheimer brain after amyloid immunization.
James E. Goldman
James E. Goldman is an American neuropathologist and Columbia University professor who has studied glial cells for over 30 years, especially Alexander disease and its GFAP genetic cause.
József Baló
József Baló (1895–1979) was a Hungarian physician, pathologist, and oncologist who described Baló's disease, a rare demyelinating brain disease, in 1928, directed pathology institutes at Szeged and Budapest, and co-discovered pancreatic elastase.
Julie A. Schneider
Julie A. Schneider is an American physician-scientist and neuropathologist at Rush University Medical Center in Chicago, known for showing that most dementia in older people arises from mixed brain pathologies.
Kenneth Aldape
Kenneth Aldape is a molecular neuropathologist at Mayo Clinic, previously chief of pathology at the National Cancer Institute, known for DNA methylation work in glioma and the WHO CNS5 tumor classification.
Linda C. Cork
Linda C. Cork is a veterinary pathologist and comparative medicine researcher who chaired Stanford's Department of Comparative Medicine from 1994 to 2009, elected to the Institute of Medicine in 1988.
Maria Martinez‐Lage
Maria Martinez-Lage Alvarez is a Spanish-trained neuropathologist and Assistant Professor of Pathology at Massachusetts General Hospital and Harvard Medical School, known for research on the immune microenvironment of gliomas.
Matthew P. Frosch
Matthew P. Frosch is an American neuropathologist who directs the C.S. Kubik Laboratory at Massachusetts General Hospital and studies Alzheimer's disease and cerebral amyloid angiopathy.
Philipp Schwartz
Philipp Schwartz (1894–1977) was a neuropathologist dismissed under Nazi law in 1933 who founded the Notgemeinschaft deutscher Wissenschaftler im Ausland, placing over 2,600 dismissed scholars worldwide.
Robert B. Jenkins
Robert B. Jenkins is an American medical geneticist and pathologist at Mayo Clinic in Rochester, Minnesota, known for molecular classification of brain tumors, especially gliomas.
Thomas J. Montine
Thomas J. Montine is an American neuropathologist and chair of Pathology at Stanford University, a National Academy of Medicine member known for the 2018 biomarker-based definition of Alzheimer's disease.